5-Year Experience in Saliva Control Clinic in a Tertiary Center: Outcome of Drooling in Children

Background: Drooling beyond age 4 is pathological, requiring investigation and intervention. The lack of a standardized approach to treating children with drooling poses a challenge in managing these patients.

Methods: A retrospective review of all children under 18 attending the saliva control clinic between 2018 and December 2023 was conducted.

Results: A total of 117 children were included. The mean age of the children was 10 years (SD = 4.74), with a male predominance of 68.4% noted. The most common comorbidity was cerebral palsy (CP), 35.9%. Twenty-nine (24.8%) of the included children were otherwise healthy. Children with CP were more likely to receive Botulinum toxin A injection (P < .001) and scopolamine patch (P < .001). Improvement was reported in 80.3%, with complications documented in 9% of children.

Conclusion: The included patients reported satisfactory results (89.7%). The importance of multidisciplinary team involvement was highlighted to ensure holistic management.

Cite this article as: Saniasiaya J, Toll E, Meer GVD. 5-year experience in saliva control clinic in a tertiary center: outcome of drooling in children. B-ENT. 2026;21(4):161-167